Table 2.

Mean T2* values of six brain region in PD patients analysed at 0, 3 and 6 months after administration of either 20 mg/kg/day or 30 mg/kg/day deferiprone or receiving placebo.

	Months	Substantia Nigra	Red Nucleus	Dentate	Caudate	Putamen	Pallidum
Placebo	0	28.09 ± 1.52	27.37 ± 0.82	30.51 ± 0.59	43.92 ± 1.22	37.26 ± 1.18	27.41 ± 1.39
	3	29.36 ± 1.84	28.76 ± 1.06	30.54 ± 0.86	43.65 ± 1.62	35.76 ± 0.90	26.25 ± 0.58
	6	28.22 ± 1.81	28.58 ± 1.23	30.74 ± 0.65	45.98 ± 2.08	36.55 ± 0.86	26.43 ± 0.87
20  mg/kg/day	0	26.41 ± 1.25	28.10 ± 1.19	29.14 ± 0.84	38.86 ± 1.53	33.99 ± 1.80	25.55 ± 1.23
	3	27.05 ± 1.23	26.86 ± 1.56	30.15 ± 0.49	40.29 ± 1.74 (**)	33.54 ± 1.27	25.43 ± 1.08
	6	27.68 ± 1.06	27.78 ± 1.05	30.59 ± 0.87 (**)	41.05 ± 3.43 (**)	33.94 ± 1.75	25.89 ± 0.96
30  mg/kg/day	0	23.89 ± 2.24	27.21 ± 1.56	27.16 ± 1.56	40.75 ± 1.68	33.67 ± 2.14	25.72 ± 1.76
	3	23.74 ± 1.84	26.99 ± 1.04	29.04 ± 1.82	44.69 ± 1.93 (**)	37.24 ± 2.31	24.97 ± 1.14
	6	24.57 ± 1.69	27.55 ± 1.12	29.86 ± 1.10 (**)	44.55 ± 1.57 (**)	38.19 ± 2.04	26.26 ± 1.33

Results are presented as mean ± standard error. **p < 0.01.